To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CLIC1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
445 supporting clones for gene CLIC1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BI116734 lung, small cell carcinoma .a 1 to 658 10 to 668   tiling clone,   659/836
(78 %)
28 diff
(96.7 %id)
BU785154 Pancreas, Purified pancreatic islet .a 11 to 481 1 to 471   tiling clone, fully sequenced,   471/471
(100 %)
2 diff
(99.6 %id)
BU784899 Pancreas, Purified pancreatic islet .a 451 to 1106 658 to 1   tiling clone, fully sequenced,   658/658
(100 %)
13 diff
(98.1 %id)
BM562536 duodenal adenocarcinoma, cell line, small intestine .b 1 to 649 1 to 649   tiling clone,   649/1053
(61 %)
2 diff
(99.9 %id)
NM_001288.4   .b 4 to 1252 1 to 1249 exact RefSeq, AAA   1249/1249
(100 %)
0 diff
(100 %id)
CR613259 Placenta Cot 25-normalized .b 7 to 1212 1 to 1206 exact     1206/1206
(100 %)
0 diff
(100 %id)
CR622923 Placenta Cot 25-normalized .b 13 to 1235 1 to 1223 exact     1223/1223
(100 %)
0 diff
(100 %id)
AL544481 placenta, Placenta Cot 25-normalized .b 13 to 680 1 to 667   fully sequenced,   667/667
(100 %)
1 diff
(99.9 %id)
CB141298 Liver .b 23 to 655 1 to 633       633/633
(100 %)
0 diff
(100 %id)
BU146311 epidermoid carcinoma, cell line, salivary gland .b 27 to 790 1 to 772       772/906
(85 %)
13 diff
(98.6 %id)
AK223379 Spleen .b 31 to 1185 1 to 1155 A136Y     1155/1155
(100 %)
3 diff
(99.8 %id)
BP340646 Spleen .b 31 to 612 1 to 582       582/582
(100 %)
0 diff
(100 %id)
AF034607 thymus .b 32 to 1254 34 to 1256 exact tiling clone,   1223/1258
(97 %)
12 diff
(99.1 %id)
BQ948689 eye, normal pigmented retinal epithelium .b 36 to 921 1 to 897       897/921
(97 %)
17 diff
(98.2 %id)
BM785216 myeloma .b 37 to 681 1 to 645       645/645
(100 %)
0 diff
(100 %id)
TI_59386992   .b 38 to 838 97 to 900       804/812
(99 %)
16 diff
(98.1 %id)
CB141132 Liver .b 38 to 656 1 to 619       619/619
(100 %)
0 diff
(100 %id)
CR593811 HeLa cells Cot 25-normalized .b 40 to 1199 1 to 1160 exact     1160/1160
(100 %)
0 diff
(100 %id)
BM908256 astrocytoma grade IV, cell line, brain .b 40 to 776 1 to 745       745/1106
(67 %)
16 diff
(98.6 %id)
BU157216 melanotic melanoma, cell line, skin .b 40 to 840 1 to 804       804/930
(86 %)
11 diff
(98.9 %id)
TI_59389142   .b 40 to 838 103 to 904       802/809
(99 %)
17 diff
(97.9 %id)
DB483959 hippocampus .b 41 to 535 1 to 495       495/495
(100 %)
1 diff
(99.8 %id)
TI_57220875   .b 44 to 834 52 to 850       799/855
(93 %)
24 diff
(97.2 %id)
BM785178 myeloma .b 47 to 678 1 to 632       632/632
(100 %)
0 diff
(100 %id)
TI_57187297   .b 48 to 714 48 to 715       668/668
(100 %)
3 diff
(99.6 %id)
BQ957436 carcinoma, cell line, Prostate .b 49 to 954 1 to 909       909/910
(99 %)
9 diff
(99.1 %id)
CX165741 human embryonic stem cells differentiated toan early endodermal cell type .b 49 to 857 1 to 809       809/809
(100 %)
0 diff
(100 %id)
CX865952 embryonic stem .b 49 to 733 1 to 685   fully sequenced,   685/685
(100 %)
0 diff
(100 %id)
BU507435 leiomyosarcoma, uterus .b 50 to 840 1 to 793       793/855
(92 %)
12 diff
(98.6 %id)
CX165203 human embryonic stem cells differentiated toan early endodermal cell type .b 50 to 725 1 to 676       676/676
(100 %)
0 diff
(100 %id)
TI_57181109   .b 50 to 770 71 to 789       719/796
(90 %)
7 diff
(99.2 %id)
TI_57166056   .b 50 to 864 31 to 837       807/838
(96 %)
11 diff
(98.7 %id)
U93205   .b 50 to 1231 1 to 1182 Q63E tiling clone, AAA   1182/1182
(100 %)
2 diff
(99.9 %id)
CR602891 placenta .b 51 to 1229 1 to 1179 exact     1179/1179
(100 %)
0 diff
(100 %id)
CR606521 Neuroblastoma Cot 50-normalized .b 51 to 1226 1 to 1176 exact     1176/1176
(100 %)
0 diff
(100 %id)
TI_57197732   .b 51 to 788 41 to 779       739/779
(94 %)
11 diff
(98.6 %id)
TI_57178387   .b 51 to 838 68 to 860       793/874
(90 %)
25 diff
(97.2 %id)
CN366689 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 53 to 718 1 to 666       666/666
(100 %)
0 diff
(100 %id)
CX759576 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 55 to 775 1 to 713     Submitted on the opposite strand 713/823
(86 %)
10 diff
(98.8 %id)
BM850168 lymph node, stomach .b 55 to 653 1 to 599       599/599
(100 %)
0 diff
(100 %id)
BM763365 myeloma .b 55 to 679 1 to 625       625/625
(100 %)
0 diff
(100 %id)
BU509378 leiomyosarcoma, uterus .b 56 to 941 1 to 886       884/929
(95 %)
14 diff
(98.5 %id)
TI_57146233   .b 56 to 866 62 to 865       804/867
(92 %)
12 diff
(98.7 %id)
TI_57146312   .b 56 to 724 26 to 705       678/846
(80 %)
34 diff
(96.0 %id)
BU528692 epidermoid carcinoma, cell line, lung .b 57 to 958 1 to 907       907/907
(100 %)
9 diff
(99.1 %id)
BP331075 rectum .b 57 to 643 1 to 587       587/587
(100 %)
0 diff
(100 %id)
CR596711 Placenta Cot 25-normalized .b 58 to 1197 1 to 1140 exact     1140/1140
(100 %)
0 diff
(100 %id)
CR619902 Placenta Cot 25-normalized .b 58 to 1200 1 to 1143 exact     1143/1143
(100 %)
0 diff
(100 %id)
CR624716 Placenta Cot 25-normalized .b 58 to 1211 1 to 1154 exact     1154/1154
(100 %)
0 diff
(100 %id)
TI_57164687   .b 58 to 750 62 to 755       694/755
(91 %)
12 diff
(98.5 %id)
TI_57189505   .b 58 to 790 52 to 782       731/731
(100 %)
4 diff
(99.5 %id)
TI_154194268   .b 58 to 950 42 to 923       882/1031
(85 %)
26 diff
(97.5 %id)
CN366693 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 60 to 819 1 to 760       760/760
(100 %)
0 diff
(100 %id)
BQ212444 large cell carcinoma, lung .b 60 to 921 1 to 875   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 875/876
(99 %)
24 diff
(97.3 %id)
CX752486 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 60 to 802 1 to 734     Submitted on the opposite strand 734/748
(98 %)
12 diff
(98.4 %id)
BP417479 small intestine .b 61 to 480 1 to 423     Submitted on the opposite strand 421/424
(99 %)
22 diff
(94.9 %id)
BQ933072 large cell carcinoma, lung .b 61 to 881 1 to 827       827/851
(97 %)
12 diff
(98.6 %id)
CX872518 embryonic stem .b 61 to 756 1 to 696       696/696
(100 %)
0 diff
(100 %id)
TI_59384184   .b 61 to 601 66 to 625       556/965
(57 %)
33 diff
(96.6 %id)
TI_59381032   .b 61 to 569 81 to 583       503/503
(100 %)
7 diff
(98.7 %id)
TI_57230005   .b 62 to 1006 86 to 1034 F114V S115F A116C Y117L I118H ...     949/952
(99 %)
29 diff
(97.0 %id)
X87689   .b 63 to 1254 1 to 1191 V8S E9N L10C F11S V12*     1191/1193
(99 %)
5 diff
(99.6 %id)
BU553534 ovary, teratocarcinoma, cell line .b 64 to 840 1 to 778       778/885
(87 %)
5 diff
(99.5 %id)
BM793644 Ascites, stomach .b 64 to 661 1 to 598       598/598
(100 %)
0 diff
(100 %id)
AA111892   .b 65 to 345 1 to 281     Submitted on the opposite strand 281/281
(100 %)
2 diff
(99.3 %id)
BU186333 large cell carcinoma, lung .b 65 to 891 1 to 838       838/839
(99 %)
10 diff
(98.9 %id)
CF128398 Chondrosarcoma Lung Metastasis cell lines, lung .b 65 to 718 1 to 654       654/654
(100 %)
0 diff
(100 %id)
TI_57198418   .b 65 to 790 37 to 760       724/760
(95 %)
8 diff
(99.0 %id)
CV569744 cornea, eye .b 65 to 696 1 to 632       632/632
(100 %)
0 diff
(100 %id)
TI_154189788   .b 65 to 838 51 to 822       772/980
(78 %)
9 diff
(99.1 %id)
BM809147 amelanotic melanoma, cell line, skin .b 66 to 1134 1 to 1100 L148P E150R E151R V152S D153G ...     1100/1113
(98 %)
73 diff
(93.5 %id)
BM916413 amelanotic melanoma, cell line, skin .b 66 to 1122 1 to 1069 C191V K192*     1069/1090
(98 %)
21 diff
(98.1 %id)
CX751458 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 67 to 772 1 to 706       706/706
(100 %)
0 diff
(100 %id)
CA396644 eye, RPE/choroid .b 68 to 652 1 to 585       585/585
(100 %)
0 diff
(100 %id)
TI_154194580   .b 68 to 1066 49 to 1036 N122X N179X L181V P182A K183X ...     988/1118
(88 %)
25 diff
(97.8 %id)
BC095469 Chondrosarcoma Lung Metastasis .b 69 to 1231 1 to 1163 exact AAA   1163/1163
(100 %)
0 diff
(100 %id)
CA405743 adipose .b 69 to 685 1 to 617       617/617
(100 %)
0 diff
(100 %id)
BM808624 amelanotic melanoma, cell line, skin .b 70 to 1107 1 to 1051 F197I T198H I199H E201R A202R ...     1051/1051
(100 %)
27 diff
(97.5 %id)
BM810917 amelanotic melanoma, cell line, skin .b 70 to 896 1 to 834       830/1075
(77 %)
17 diff
(98.5 %id)
BQ688570 ductal carcinoma, cell line, Pancreas .b 70 to 907 1 to 849       849/933
(90 %)
19 diff
(98.0 %id)
BP289079 lung .b 70 to 653 1 to 584       584/584
(100 %)
0 diff
(100 %id)
BM811078 amelanotic melanoma, cell line, skin .b 71 to 839 1 to 771       771/1111
(69 %)
18 diff
(98.4 %id)
BU529092 epidermoid carcinoma, cell line, lung .b 71 to 834 1 to 766       766/918
(83 %)
6 diff
(99.4 %id)
CV572775 cornea, eye .b 71 to 687 1 to 617       617/617
(100 %)
0 diff
(100 %id)
BQ893177 melanotic melanoma, cell line, skin .b 72 to 934 1 to 872       872/910
(95 %)
17 diff
(98.2 %id)
CR623346 placenta .b 73 to 1236 1 to 1164 exact     1164/1164
(100 %)
0 diff
(100 %id)
CN366732 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 74 to 815 1 to 742       742/742
(100 %)
0 diff
(100 %id)
TI_59384527   .b 74 to 792 62 to 779       718/718
(100 %)
10 diff
(98.7 %id)
BM911574 amelanotic melanoma, cell line, skin .b 75 to 832 1 to 762       762/1144
(66 %)
16 diff
(98.7 %id)
BU145352 melanotic melanoma, cell line, skin .b 75 to 963 1 to 907       907/920
(98 %)
25 diff
(97.3 %id)
BQ676585 melanotic melanoma, cell line, skin .b 75 to 776 1 to 704       704/1012
(69 %)
11 diff
(99.0 %id)
BE385294 melanotic melanoma, skin .b 80 to 664 1 to 585       585/585
(100 %)
0 diff
(100 %id)
BM913207 amelanotic melanoma, cell line, skin .b 80 to 838 1 to 761       761/1111
(68 %)
5 diff
(99.6 %id)
CX784576 human embryonic stem cells .b 80 to 855 1 to 776       776/776
(100 %)
0 diff
(100 %id)
BM423696 amelanotic melanoma, cell line, skin .b 81 to 1005 1 to 939 F167V N171H N179H V190G C191V ...     939/1029
(91 %)
31 diff
(97.0 %id)
TI_59385503   .b 81 to 648 58 to 635       557/736
(75 %)
24 diff
(96.8 %id)
CU455496 epidermis .b 83 to 607 24 to 548       525/548
(95 %)
7 diff
(98.8 %id)
BQ686125 ductal carcinoma, cell line, Pancreas .b 84 to 1010 1 to 933 C191V K192*     933/933
(100 %)
17 diff
(98.2 %id)
BQ928503 carcinoma, cell line, Prostate .b 84 to 933 1 to 862       862/962
(89 %)
22 diff
(97.8 %id)
BQ952696 carcinoma, cell line, Prostate .b 84 to 794 1 to 719       719/968
(74 %)
27 diff
(97.3 %id)
TI_59391150   .b 84 to 792 101 to 810       710/710
(100 %)
9 diff
(98.8 %id)
BM555133 amelanotic melanoma, cell line, skin .b 85 to 834 1 to 750       750/1063
(70 %)
3 diff
(99.8 %id)
TI_154194557   .b 85 to 989 44 to 941       898/1021
(87 %)
16 diff
(98.5 %id)
ES307691 beard hair, skin .b 86 to 233 1 to 148       148/149
(99 %)
1 diff
(99.4 %id)
BM808153 amelanotic melanoma, cell line, skin .b 86 to 998 1 to 927 L181V I199H E201R A202G F203P ...     927/1061
(87 %)
24 diff
(97.8 %id)
BM915416 amelanotic melanoma, cell line, skin .b 86 to 1037 1 to 965 T198H E201R V206S H207A R208S ...     965/1025
(94 %)
28 diff
(97.3 %id)
TI_57221305   .b 86 to 632 90 to 641       552/1409
(39 %)
24 diff
(98.3 %id)
CB850584 lung, Primary Lung Epithelial Cells .b 86 to 801 1 to 715     Submitted on the opposite strand 715/715
(100 %)
6 diff
(99.2 %id)
CD611180   .b 87 to 807 733 to 17       717/733
(97 %)
3 diff
(99.6 %id)
BE877737 large cell carcinoma, undifferentiated, lung .b 87 to 583 1 to 510       508/670
(75 %)
20 diff
(97.1 %id)
BQ691382 ductal carcinoma, cell line, Pancreas .b 87 to 939 1 to 864       864/944
(91 %)
18 diff
(98.1 %id)
CF131111 Chondrosarcoma Lung Metastasis cell lines, lung .b 87 to 838 1 to 752       752/752
(100 %)
0 diff
(100 %id)
BU186790 epithelioid carcinoma, Pancreas .b 88 to 994 1 to 917 F167V L168F D169G G170W N171Q ...     818/917
(89 %)
20 diff
(97.9 %id)
TI_154193076   .b 88 to 917 50 to 873       824/964
(85 %)
12 diff
(98.8 %id)
CF127549 Chondrosarcoma Lung Metastasis cell lines, lung .b 89 to 757 1 to 670       670/670
(100 %)
1 diff
(99.9 %id)
CR596449 Placenta Cot 25-normalized .b 90 to 1230 1 to 1141 exact     1141/1141
(100 %)
0 diff
(100 %id)
DR156072 human embryonic stem cells differentiated toan early endodermal cell type .b 91 to 893 1 to 803       803/803
(100 %)
0 diff
(100 %id)
BG763222 melanotic melanoma, high MDR (cell line), skin .b 93 to 792 1 to 700       700/700
(100 %)
2 diff
(99.8 %id)
TI_59394630   .b 93 to 834 83 to 822       740/743
(99 %)
8 diff
(99.0 %id)
TI_149304504   .b 93 to 838 53 to 794     Submitted on the opposite strand 742/1004
(73 %)
17 diff
(98.4 %id)
BP420988 small intestine .b 95 to 591 1 to 499     Submitted on the opposite strand 499/499
(100 %)
2 diff
(99.6 %id)
BQ962673 leiomyosarcoma, uterus .b 101 to 840 1 to 740       740/914
(80 %)
6 diff
(99.4 %id)
BM454763 leiomyosarcoma, uterus .b 104 to 1134 1 to 1050 L175P A176G D177*     1050/1081
(97 %)
45 diff
(95.9 %id)
TI_149282476   .b 107 to 840 1 to 733     Submitted on the opposite strand 733/734
(99 %)
6 diff
(99.2 %id)
BQ935946 carcinoma, cell line, Prostate .b 121 to 1037 1 to 936 L168F D169G G170W N171A E172R ...     936/938
(99 %)
28 diff
(97.1 %id)
BQ691014 ductal carcinoma, cell line, Pancreas .b 130 to 881 1 to 757       757/909
(83 %)
7 diff
(99.3 %id)
CN366711 embryonic stem cells, cell lines H1, H7, andH9 .b 140 to 832 1 to 693       693/694
(99 %)
3 diff
(99.6 %id)
CN366724 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 141 to 869 1 to 730       730/730
(100 %)
1 diff
(99.9 %id)
BE273418 Kidney, renal cell adenocarcinoma .b 148 to 1004 1 to 860 L168W D169M G170A N171T E172R ...     860/927
(92 %)
25 diff
(97.4 %id)
BM790253 Ascites, stomach .b 154 to 745 1 to 592       592/592
(100 %)
0 diff
(100 %id)
BU789595 insulinoma, Pancreas .b 156 to 680 11 to 535   fully sequenced, Submitted on the opposite strand 524/534
(98 %)
6 diff
(98.9 %id)
BQ417451 Pancreas, Purified pancreatic islet .b 159 to 680 1 to 522   fully sequenced,   522/522
(100 %)
0 diff
(100 %id)
CR977835 T-Lymphocytes .b 182 to 945 1 to 764       764/765
(99 %)
1 diff
(99.9 %id)
TI_154189723   .b 185 to 1081 50 to 932 K183X C191X K192*     883/1023
(86 %)
26 diff
(97.5 %id)
AL570691 placenta, Placenta Cot 25-normalized .b 619 to 1224 617 to 12   fully sequenced,   606/617
(98 %)
0 diff
(100 %id)
BU789869 insulinoma, Pancreas .b 626 to 1215 606 to 17   fully sequenced, Submitted on the opposite strand 590/606
(97 %)
0 diff
(100 %id)
BQ287995 Pancreas, Purified pancreatic islet .b 635 to 1233 599 to 1   fully sequenced,   599/599
(100 %)
0 diff
(100 %id)
CX865887 embryonic stem .b 703 to 1238 561 to 26   fully sequenced, AAA   536/536
(100 %)
2 diff
(99.7 %id)
AW800894 uterus .b 822 to 1074 261 to 10       252/274
(91 %)
0 diff
(100 %id)
BE906716 epithelioid carcinoma, Pancreas .b 829 to 1236 424 to 18     Submitted on the opposite strand 407/841
(48 %)
0 diff
(100 %id)
BM917927 blood, natural killer cells, cell line .b 829 to 1240 445 to 34     Submitted on the opposite strand 412/1181
(34 %)
0 diff
(100 %id)
AA085692   .b 849 to 1220 378 to 1     Submitted on the opposite strand 378/384
(98 %)
6 diff
(98.5 %id)
AA551612 normal prostatic epithelial cells, Prostate .b 853 to 1240 403 to 17       387/403
(96 %)
0 diff
(100 %id)
T34324 blood, white blood cells .b 858 to 1236 383 to 5     Submitted on the opposite strand 379/385
(98 %)
0 diff
(100 %id)
AV735343 cord Blood .b 863 to 1229 378 to 20     Submitted on the opposite strand 359/383
(93 %)
0 diff
(100 %id)
AA613773   .b 865 to 983 118 to 1       118/118
(100 %)
3 diff
(97.5 %id)
AW362794 colon .b 876 to 1201 338 to 12       327/369
(88 %)
0 diff
(100 %id)
G43219   .b 887 to 1153 267 to 1     Submitted on the opposite strand 267/267
(100 %)
0 diff
(100 %id)
EC553405 Prostate .b 888 to 979 92 to 1       92/92
(100 %)
0 diff
(100 %id)
AA948422 adenocarcinoma, colon .b 916 to 973 58 to 1       58/58
(100 %)
1 diff
(98.3 %id)
BP418763 small intestine .b 917 to 1236 1 to 320     Submitted on the opposite strand 320/321
(99 %)
1 diff
(99.7 %id)
BF211235 bone marrow, from chronic myelogenous leukemia .b 917 to 969 1 to 53       53/53
(100 %)
1 diff
(98.2 %id)
BF812759 colon_ins .b 919 to 1164 247 to 2     Submitted on the opposite strand 246/248
(99 %)
0 diff
(100 %id)
T35544 lung .b 922 to 1254 337 to 3     Submitted on the opposite strand 335/337
(99 %)
0 diff
(100 %id)
AA852268 Bone, Hip .b 946 to 1241 304 to 9       296/304
(97 %)
0 diff
(100 %id)
AA661913 metastatic prostate bone lesion .b 953 to 1240 293 to 4       290/293
(98 %)
0 diff
(100 %id)
BG154207 nasopharynx, normal epithelium .b 1004 to 1236 241 to 9       233/241
(96 %)
0 diff
(100 %id)
BG150800 nasopharynx, normal epithelium .b 1006 to 1236 239 to 9       231/239
(96 %)
0 diff
(100 %id)
EC471349 Prostate .b 1112 to 1230 119 to 3       117/119
(98 %)
0 diff
(100 %id)
BF030500 hypernephroma, Kidney .b 1160 to 1240 1 to 81       81/91
(89 %)
2 diff
(97.9 %id)
AI583047 adenocarcinoma, Pancreas .b 1172 to 1231 73 to 14   AAA   60/60
(100 %)
1 diff
(98.4 %id)
CX783058 human embryonic stem cells .c 1 to 706 1 to 706   tiling clone, fully sequenced,   706/706
(100 %)
0 diff
(100 %id)
AA356595   .c 14 to 256 1 to 244       244/244
(100 %)
5 diff
(98.0 %id)
BI523676 pooled lung and spleen .c 14 to 377 1 to 362       362/711
(50 %)
7 diff
(99.1 %id)
CD704359 normal nasopharynx .c 19 to 522 26 to 529       504/529
(95 %)
8 diff
(98.5 %id)
BG687620 lung, mucoepidermoid carcinoma .c 22 to 813 1 to 796       796/796
(100 %)
22 diff
(97.3 %id)
BG776428 lung, mucoepidermoid carcinoma .c 22 to 790 1 to 763       763/763
(100 %)
16 diff
(98.0 %id)
BQ227563 melanotic melanoma, skin .c 22 to 842 12 to 836 E217G S221F D225X D226*     825/884
(93 %)
14 diff
(98.5 %id)
CN366733 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 36 to 597 3 to 564       562/564
(99 %)
7 diff
(98.8 %id)
BG491600 amelanotic melanoma, cell line, skin .c 39 to 712 1 to 677       677/677
(100 %)
6 diff
(99.2 %id)
BM009514 amelanotic melanoma, cell line, skin .c 39 to 884 1 to 849 Q63S L64S P65H F66S L67C ... tiling clone,   849/852
(99 %)
12 diff
(98.6 %id)
TI_59384262   .c 39 to 884 62 to 910 Q63S L64S P65H F66S L67C ...     849/852
(99 %)
12 diff
(98.6 %id)
BM912822 amelanotic melanoma, cell line, skin .c 41 to 664 1 to 629       629/1127
(55 %)
28 diff
(97.6 %id)
BM914965 amelanotic melanoma, cell line, skin .c 41 to 656 1 to 618       618/1081
(57 %)
10 diff
(99.1 %id)
BG677247 skin, squamous cell carcinoma .c 44 to 809 1 to 764       764/764
(100 %)
15 diff
(98.1 %id)
BU151662 ductal carcinoma, cell line, Pancreas .c 49 to 800 1 to 760       760/1074
(70 %)
12 diff
(98.9 %id)
BG260026 bladder, transitional cell papilloma, cell line .c 51 to 855 1 to 795 Q63S L64S P65H F66S L67C ...     795/899
(88 %)
28 diff
(96.9 %id)
CX782986 human embryonic stem cells .c 645 to 1082 468 to 31   tiling clone, fully sequenced, AAA   438/438
(100 %)
5 diff
(98.9 %id)
BC064527 Testis, embryonal carcinoma .d 1 to 1558 1 to 1558 exact tiling clone, available from MGC, AAA   1558/1558
(100 %)
0 diff
(100 %id)
BM469473 embryonal carcinoma, cell line, testis .d 1 to 729 1 to 739       739/1070
(69 %)
21 diff
(98.1 %id)
AF109197   .d 521 to 1536 1 to 1017 Q63E     1017/1017
(100 %)
7 diff
(99.4 %id)
AW672868 cervix .d 523 to 1033 1 to 511   fully sequenced,   511/511
(100 %)
4 diff
(99.3 %id)
TI_57151388   .d 543 to 1410 17 to 895 D17E G18W A19G K20Q I21D ...     879/895
(98 %)
36 diff
(96.0 %id)
BQ691712 ductal carcinoma, cell line, Pancreas .d 549 to 1417 1 to 869 exact     869/872
(99 %)
5 diff
(99.5 %id)
BQ690431 ductal carcinoma, cell line, Pancreas .d 549 to 1400 1 to 860 E217G E218R F219I A220R S221F ...     860/962
(89 %)
15 diff
(98.5 %id)
CR590898 Neuroblastoma Cot 25-normalized .d 560 to 1542 1 to 983 exact     983/983
(100 %)
0 diff
(100 %id)
CR607137 HeLa cells Cot 25-normalized .d 560 to 1508 1 to 949 exact     949/949
(100 %)
0 diff
(100 %id)
CR613236 placenta .d 560 to 1546 1 to 987 exact     987/987
(100 %)
0 diff
(100 %id)
CR997899 T-Lymphocytes .d 562 to 1469 1 to 909 exact     909/911
(99 %)
6 diff
(99.4 %id)
BG537386 lung .d 563 to 1284 1 to 677       590/810
(72 %)
45 diff
(94.5 %id)
CN366736 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 564 to 1161 1 to 598       598/598
(100 %)
0 diff
(100 %id)
BM463766 leiomyosarcoma, uterus .d 564 to 1440 1 to 877 exact     877/1045
(83 %)
6 diff
(99.5 %id)
AK129773 dermoid tumor .d 565 to 1537 1 to 973 exact available from FLJ,   973/973
(100 %)
0 diff
(100 %id)
AK314014 trachea .d 565 to 1299 1 to 735 exact     735/735
(100 %)
0 diff
(100 %id)
CR594574 Placenta Cot 25-normalized .d 565 to 1531 1 to 967 exact     967/967
(100 %)
0 diff
(100 %id)
DT220187 brain .d 565 to 1221 1 to 657       657/657
(100 %)
1 diff
(99.9 %id)
BG397220 melanotic melanoma, skin .d 568 to 1409 1 to 839 exact     839/839
(100 %)
3 diff
(99.7 %id)
BM548876 duodenal adenocarcinoma, cell line, small intestine .d 569 to 1421 1 to 868 A202X R216P E217X E218R F219N ...     868/990
(87 %)
34 diff
(96.6 %id)
BU543415 carcinoma, cell line, Prostate .d 569 to 1399 1 to 839 exact     839/905
(92 %)
16 diff
(98.3 %id)
TI_57230935   .d 570 to 1392 54 to 873 K13R L168S N179K L180P L181V ...     820/822
(99 %)
17 diff
(98.0 %id)
BF796054 lymph, lymphoma, cell line .d 571 to 1448 1 to 867 L240S K241N     867/1025
(84 %)
33 diff
(96.8 %id)
TI_57174469   .d 572 to 1412 26 to 867 A2I     842/867
(97 %)
8 diff
(99.1 %id)
TI_1948214762   .d 573 to 800 125 to 352       228/255
(89 %)
6 diff
(97.7 %id)
TI_1948214930   .d 573 to 794 132 to 353       222/249
(89 %)
6 diff
(97.6 %id)
TI_1948215109   .d 573 to 749 134 to 310       177/204
(86 %)
6 diff
(97.1 %id)
TI_1948215286   .d 573 to 1305 852 to 115 E4G Q5T P6N Q7R V8R ...     738/1202
(61 %)
9 diff
(99.3 %id)
CR542071   .d 574 to 1296 1 to 723       723/723
(100 %)
0 diff
(100 %id)
EL735042 mixed .d 574 to 1237 1 to 663       663/663
(100 %)
1 diff
(99.9 %id)
CN366719 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 577 to 1337 1 to 761       761/761
(100 %)
2 diff
(99.8 %id)
CD671680 eye, Iris .d 577 to 1221 1 to 645       645/645
(100 %)
0 diff
(100 %id)
BG747632 eye, normal pigmented retinal epithelium .d 577 to 1174 1 to 598       598/598
(100 %)
0 diff
(100 %id)
CN366692 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 578 to 1224 1 to 647       647/647
(100 %)
0 diff
(100 %id)
BQ219435 epithelioid carcinoma, Pancreas .d 578 to 1498 1 to 923       923/924
(99 %)
21 diff
(97.8 %id)
BI827155 brain, medulla .d 579 to 1412 1 to 835       835/835
(100 %)
2 diff
(99.8 %id)
BU160300 melanotic melanoma, skin .d 579 to 1354 1 to 784       784/933
(84 %)
23 diff
(97.6 %id)
BQ933570 sciatic nerve .d 579 to 1462 1 to 896       896/898
(99 %)
17 diff
(98.2 %id)
TI_154189218   .d 579 to 1504 51 to 960       910/1026
(88 %)
26 diff
(97.5 %id)
BU159329 epithelioid carcinoma, Pancreas .d 583 to 1325 1 to 747       747/814
(91 %)
5 diff
(99.4 %id)
CA771282 Pancreas, Purified pancreatic islet .d 583 to 1107 8 to 532   fully sequenced,   525/532
(98 %)
6 diff
(98.9 %id)
BU172314 melanotic melanoma, skin .d 583 to 1343 1 to 771       771/885
(87 %)
14 diff
(98.5 %id)
CR996581 T-Lymphocytes .d 583 to 1494 1 to 912       912/913
(99 %)
6 diff
(99.4 %id)
CR988696 T-Lymphocytes .d 583 to 1448 1 to 868       868/870
(99 %)
6 diff
(99.4 %id)
CN485048 eye .d 584 to 1223 1 to 640       640/640
(100 %)
0 diff
(100 %id)
BU846299 ovary, teratocarcinoma, cell line .d 584 to 1469 1 to 897       897/910
(98 %)
11 diff
(98.8 %id)
BE889593 leiomyosarcoma, uterus .d 585 to 1334 1 to 746       746/749
(99 %)
15 diff
(98.0 %id)
TI_57186229   .d 585 to 1349 59 to 824       766/766
(100 %)
3 diff
(99.7 %id)
CN483148 eye .d 586 to 1174 1 to 589       589/589
(100 %)
0 diff
(100 %id)
BU192657 epithelioid carcinoma, Pancreas .d 586 to 1420 1 to 843       843/887
(95 %)
18 diff
(98.0 %id)
CT001293 T-Lymphocytes .d 586 to 1244 1 to 660       660/660
(100 %)
2 diff
(99.7 %id)
CT000827 T-Lymphocytes .d 589 to 1486 1 to 901       901/908
(99 %)
13 diff
(98.6 %id)
CB594915 Blood, promyelocytic leukemia .d 590 to 1469 26 to 922       897/927
(96 %)
27 diff
(97.1 %id)
BE264424 lung, small cell carcinoma .d 592 to 1195 1 to 604       604/604
(100 %)
0 diff
(100 %id)
BU845424 ovary, teratocarcinoma, cell line .d 592 to 1497 1 to 917       917/944
(97 %)
33 diff
(96.6 %id)
BU859508 ovary, teratocarcinoma, cell line .d 592 to 1442 1 to 860       860/864
(99 %)
20 diff
(97.7 %id)
CA848437 Pancreas, Purified pancreatic islet .d 594 to 1085 1 to 492   fully sequenced,   492/492
(100 %)
0 diff
(100 %id)
CF126172 Chondrosarcoma Lung Metastasis cell lines, lung .d 598 to 1283 1 to 686       686/686
(100 %)
0 diff
(100 %id)
TI_154060736   .d 598 to 1444 68 to 899     Submitted on the opposite strand 832/1007
(82 %)
15 diff
(98.6 %id)
TI_154189124   .d 598 to 1446 51 to 893       843/1010
(83 %)
13 diff
(98.8 %id)
BM352437 Pancreas, Purified pancreatic islet .d 602 to 1212 1 to 611       611/611
(100 %)
0 diff
(100 %id)
CA777100 Pancreas, Purified pancreatic islet .d 602 to 1064 1 to 463       463/463
(100 %)
1 diff
(99.8 %id)
TI_154061486   .d 606 to 1537 1017 to 91   AAA   927/984
(94 %)
67 diff
(93.2 %id)
BQ434983 melanotic melanoma, skin .d 611 to 1400 24 to 823       800/855
(93 %)
19 diff
(97.8 %id)
BG035696 adenocarcinoma, cell line, Liver .d 615 to 1294 1 to 680       680/680
(100 %)
0 diff
(100 %id)
BM550884 amelanotic melanoma, cell line, skin .d 615 to 1502 1 to 890       890/1066
(83 %)
15 diff
(98.6 %id)
BQ218234 epithelioid carcinoma, Pancreas .d 615 to 1481 1 to 870       870/870
(100 %)
6 diff
(99.4 %id)
TI_149287153   .d 617 to 1537 977 to 65   AAA   913/1093
(83 %)
33 diff
(97.0 %id)
TI_149298996   .d 623 to 1558 1010 to 86   AAA   925/983
(94 %)
17 diff
(98.3 %id)
TI_149311689   .d 627 to 1544 993 to 87   AAA   907/964
(94 %)
22 diff
(97.8 %id)
BI524830 pooled lung and spleen .d 629 to 1489 868 to 2       867/872
(99 %)
10 diff
(98.9 %id)
TI_44159264   .d 629 to 1489 868 to 2       867/872
(99 %)
10 diff
(98.9 %id)
TI_59395178   .d 634 to 1371 155 to 941       657/881
(74 %)
37 diff
(95.9 %id)
BM910588 astrocytoma grade IV, cell line, brain .d 636 to 1544 1 to 915       915/1060
(86 %)
21 diff
(98.1 %id)
CK822392 Pancreas, Purified pancreatic islet .d 637 to 1208 1 to 572     Submitted on the opposite strand 572/572
(100 %)
0 diff
(100 %id)
TI_149287175   .d 638 to 1537 957 to 65   AAA   895/1093
(81 %)
25 diff
(97.8 %id)
CU448846 epidermis .d 647 to 1254 6 to 613       608/626
(97 %)
7 diff
(98.9 %id)
BU857234 adenocarcinoma, cell line, breast .d 653 to 1537 1 to 886       886/891
(99 %)
10 diff
(98.9 %id)
TI_154055869   .d 654 to 1537 957 to 86   AAA   872/932
(93 %)
13 diff
(98.7 %id)
BM554940 amelanotic melanoma, cell line, skin .d 656 to 1469 1 to 819       819/1103
(74 %)
8 diff
(99.3 %id)
TI_154142899   .d 656 to 1254 80 to 677       598/598
(100 %)
11 diff
(98.2 %id)
CR602015 Neuroblastoma Cot 25-normalized .d 664 to 1546 1 to 883       883/883
(100 %)
0 diff
(100 %id)
BU521719 leiomyosarcoma, uterus .d 672 to 1527 1 to 873   AAA   873/897
(97 %)
27 diff
(97.0 %id)
CN484722 eye .d 675 to 1282 1 to 608       608/608
(100 %)
0 diff
(100 %id)
TI_154093477   .d 678 to 1544 953 to 94   AAA   860/992
(86 %)
20 diff
(98.0 %id)
BI870954 adenocarcinoma, cell line, Liver .d 683 to 1546 1 to 862       862/864
(99 %)
21 diff
(97.6 %id)
BQ441647 epithelioid carcinoma, Pancreas .d 683 to 1469 1 to 795       795/808
(98 %)
10 diff
(98.8 %id)
TI_57230928   .d 683 to 1546 54 to 915       862/896
(96 %)
21 diff
(97.7 %id)
BM793274 Ascites, stomach .d 683 to 1314 1 to 632       632/632
(100 %)
1 diff
(99.9 %id)
TI_154193852   .d 688 to 1514 50 to 865       816/1004
(81 %)
19 diff
(98.2 %id)
GD156017   .d 697 to 1285 1 to 585       585/685
(85 %)
43 diff
(93.8 %id)
BE614994 adenocarcinoma, Pancreas .d 701 to 1494 1 to 801       801/1061
(75 %)
19 diff
(98.3 %id)
BU855729 ovary, teratocarcinoma, cell line .d 702 to 1544 1 to 850   AAA   850/850
(100 %)
13 diff
(98.5 %id)
BQ217079 embryonal carcinoma, cell line, testis .d 706 to 1498 192 to 989       798/805
(99 %)
25 diff
(96.9 %id)
BF769508 epid_tumor .d 714 to 1281 581 to 15     Submitted on the opposite strand 567/581
(97 %)
1 diff
(99.9 %id)
TI_149288065   .d 721 to 1537 885 to 85   AAA   801/963
(83 %)
24 diff
(97.6 %id)
TI_154032508   .d 721 to 1554 896 to 64   AAA   833/962
(86 %)
9 diff
(99.1 %id)
TI_154126320   .d 721 to 1544 883 to 67   AAA   817/971
(84 %)
20 diff
(98.0 %id)
TI_149301429   .d 723 to 1537 817 to 13   AAA   805/931
(86 %)
17 diff
(98.2 %id)
TI_154054584   .d 723 to 1544 898 to 92   AAA   807/964
(83 %)
23 diff
(97.7 %id)
TI_149295615   .d 726 to 1537 882 to 85   AAA   798/915
(87 %)
29 diff
(96.9 %id)
TI_149311586   .d 726 to 1537 897 to 88   AAA   810/947
(85 %)
5 diff
(99.5 %id)
TI_154062147   .d 726 to 1544 902 to 96   AAA   807/967
(83 %)
21 diff
(97.9 %id)
BM854112 Ascites, stomach .d 731 to 1391 1 to 661       661/661
(100 %)
0 diff
(100 %id)
CA418760 Chondrosarcoma Grade II, Left Pelvis .d 731 to 1537 821 to 19   AAA   803/803
(100 %)
4 diff
(99.6 %id)
BQ680267 melanotic melanoma, cell line, skin .d 741 to 1537 1 to 798   AAA   798/798
(100 %)
4 diff
(99.5 %id)
TI_154100567   .d 745 to 1537 862 to 82   AAA   781/800
(97 %)
11 diff
(98.7 %id)
AI971375 pooled germ cell tumors .d 751 to 1543 793 to 1       793/793
(100 %)
7 diff
(99.2 %id)
BU856705 adenocarcinoma, cell line, breast .d 759 to 1558 821 to 20   AAA Submitted on the opposite strand 802/914
(87 %)
2 diff
(99.8 %id)
CB850529 lung, Primary Lung Cystic Fibrosis EpithelialCells .d 767 to 1558 811 to 19   AAA   793/793
(100 %)
4 diff
(99.5 %id)
CN366735 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 769 to 1470 1 to 702       702/702
(100 %)
2 diff
(99.8 %id)
BE928631 denis_drash .d 780 to 1207 468 to 40       429/468
(91 %)
3 diff
(99.4 %id)
ES310738 scalp interfollicular dermis, skin .d 792 to 1279 19 to 505       487/506
(96 %)
7 diff
(98.7 %id)
TI_154191077   .d 792 to 1545 50 to 806       757/994
(76 %)
8 diff
(99.2 %id)
BM423525 amelanotic melanoma, cell line, skin .d 796 to 1537 1 to 743   AAA   743/743
(100 %)
3 diff
(99.6 %id)
TI_57191502   .d 806 to 1546 51 to 791       741/822
(90 %)
8 diff
(99.1 %id)
AA402361   .d 807 to 1266 1 to 459   fully sequenced,   459/459
(100 %)
1 diff
(99.8 %id)
TI_154192192   .d 816 to 1544 51 to 780   AAA   730/730
(100 %)
6 diff
(99.2 %id)
CA308000 Alveolar Macrophage, lung .d 825 to 1558 752 to 19   AAA   734/734
(100 %)
1 diff
(99.9 %id)
BI092497 cervix .d 826 to 1541 1 to 717       717/745
(96 %)
6 diff
(99.2 %id)
BI053441 placenta_normal .d 830 to 1230 403 to 3       401/403
(99 %)
3 diff
(99.3 %id)
BE302713 melanotic melanoma, skin .d 830 to 1168 1 to 339   fully sequenced,   339/339
(100 %)
0 diff
(100 %id)
BQ683391 melanotic melanoma, cell line, skin .d 833 to 1546 1 to 714   AAA   714/714
(100 %)
1 diff
(99.9 %id)
BF808643 colon_ins .d 834 to 1222 418 to 28     Submitted on the opposite strand 391/418
(93 %)
1 diff
(99.8 %id)
TI_154061544   .d 839 to 1544 817 to 114   AAA   704/927
(75 %)
9 diff
(99.1 %id)
TI_157613178   .d 842 to 1558 806 to 90   AAA   717/722
(99 %)
20 diff
(97.3 %id)
TI_149291734   .d 845 to 1544 781 to 80   AAA   657/705
(93 %)
20 diff
(97.2 %id)
AW383616 head_neck .d 847 to 1362 516 to 1       516/516
(100 %)
7 diff
(98.7 %id)
TI_154124811   .d 848 to 1546 789 to 91       699/1004
(69 %)
10 diff
(99.1 %id)
TI_149278048   .d 849 to 1537 764 to 82   AAA   683/683
(100 %)
5 diff
(99.3 %id)
TI_149289619   .d 849 to 1544 791 to 101   AAA   691/911
(75 %)
9 diff
(99.1 %id)
TI_149308915   .d 849 to 1537 770 to 86   AAA   685/947
(72 %)
6 diff
(99.4 %id)
TI_154061532   .d 849 to 1537 775 to 91   AAA   685/953
(71 %)
10 diff
(99.0 %id)
TI_154062167   .d 849 to 1544 790 to 104   AAA   687/915
(75 %)
13 diff
(98.6 %id)
TI_154110673   .d 849 to 1558 785 to 80   AAA   706/929
(75 %)
9 diff
(99.1 %id)
CA426738 cell lines, Chondrosarcoma .d 849 to 1544 714 to 19   AAA   696/696
(100 %)
0 diff
(100 %id)
BU858236 adenocarcinoma, cell line, breast .d 850 to 1557 738 to 20   AAA Submitted on the opposite strand 719/812
(88 %)
14 diff
(98.3 %id)
TI_154125113   .d 853 to 1537 789 to 102   AAA   688/919
(74 %)
18 diff
(98.1 %id)
CU447885 epidermis .d 860 to 1263 428 to 24     Submitted on the opposite strand 405/435
(93 %)
2 diff
(99.6 %id)
AW819734 stomach .d 865 to 1487 626 to 6       621/626
(99 %)
4 diff
(99.4 %id)
AW170098 cervix, tumor .d 865 to 1558 694 to 1       694/694
(100 %)
6 diff
(99.2 %id)
AI816731 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .d 874 to 1539 665 to 1       665/668
(99 %)
2 diff
(99.8 %id)
BU627289 Bone, Enchondroma cell line .d 876 to 1537 680 to 19   AAA   662/662
(100 %)
0 diff
(100 %id)
BU628792 Bone, Enchondroma cell line .d 882 to 1544 681 to 19   AAA   663/663
(100 %)
0 diff
(100 %id)
CA422340 Bone, Enchondroma cell line .d 891 to 1544 672 to 19   AAA   654/654
(100 %)
0 diff
(100 %id)
CV381321 uterus_tumor .d 903 to 1205 49 to 356       308/356
(86 %)
17 diff
(95.3 %id)
BY993687   .d 909 to 1544 681 to 46   AAA Submitted on the opposite strand 636/636
(100 %)
0 diff
(100 %id)
BM829930 stomach .d 912 to 1521 1 to 610       610/610
(100 %)
0 diff
(100 %id)
CA435294 Fibrosarcoma .d 914 to 1544 649 to 19   AAA   631/633
(99 %)
0 diff
(100 %id)
BU627322 Bone, Enchondroma cell line .d 923 to 1558 654 to 19   AAA   636/636
(100 %)
1 diff
(99.9 %id)
BU627466 Bone, Enchondroma cell line .d 923 to 1537 633 to 19   AAA   615/615
(100 %)
0 diff
(100 %id)
CA308662 Alveolar Macrophage, lung .d 923 to 1546 668 to 45   AAA   624/651
(95 %)
0 diff
(100 %id)
CA941746 Pancreas, Purified pancreatic islet .d 928 to 1168 1 to 241   fully sequenced,   241/241
(100 %)
0 diff
(100 %id)
BI855707 breast, mammary adenocarcinoma, cell line .d 935 to 1546 1 to 612       612/619
(98 %)
3 diff
(99.6 %id)
TI_57186346   .d 935 to 1546 56 to 667       612/694
(88 %)
3 diff
(99.6 %id)
TI_154192713   .d 940 to 1544 51 to 656   AAA   606/606
(100 %)
1 diff
(99.9 %id)
BF372473 prostate_tumor .d 955 to 1241 317 to 30       288/325
(88 %)
6 diff
(98.2 %id)
BQ001935 lung, Metastatic Chondrosarcoma .d 956 to 1544 607 to 19   AAA   589/613
(96 %)
0 diff
(100 %id)
BQ000865 lung, Metastatic Chondrosarcoma .d 956 to 1554 617 to 19   AAA   599/621
(96 %)
0 diff
(100 %id)
TI_154103610   .d 956 to 1537 645 to 69   AAA   577/787
(73 %)
10 diff
(98.8 %id)
TI_157612656   .d 956 to 1537 670 to 83   AAA   588/599
(98 %)
27 diff
(95.5 %id)
CK822393 Pancreas, Purified pancreatic islet .d 964 to 1552 589 to 1     Submitted on the opposite strand 589/589
(100 %)
0 diff
(100 %id)
TI_157613570   .d 965 to 1537 659 to 87   AAA   571/573
(99 %)
6 diff
(99.0 %id)
BE714835 head_neck .d 967 to 1367 405 to 5       401/405
(99 %)
0 diff
(100 %id)
BM352117 Pancreas, Purified pancreatic islet .d 967 to 1557 591 to 1       591/591
(100 %)
0 diff
(100 %id)
TI_154191149   .d 972 to 1537 52 to 617   AAA   566/566
(100 %)
0 diff
(100 %id)
AW732505 Kidney, renal cell adenocarcinoma .d 979 to 1536 584 to 28   AAA Submitted on the opposite strand 557/557
(100 %)
3 diff
(99.5 %id)
AV740784 cord Blood .d 992 to 1535 557 to 20     Submitted on the opposite strand 538/593
(90 %)
8 diff
(98.7 %id)
T11650   .d 995 to 1206 210 to 1       210/210
(100 %)
10 diff
(95.3 %id)
AW675457 cervix .d 1003 to 1542 540 to 1   fully sequenced,   540/540
(100 %)
0 diff
(100 %id)
BQ318936 colon .d 1006 to 1441 436 to 1       436/442
(98 %)
5 diff
(98.9 %id)
BQ318942 colon .d 1006 to 1492 490 to 4       487/496
(98 %)
2 diff
(99.6 %id)
BE826142 lung_normal .d 1012 to 1378 371 to 9       363/371
(97 %)
22 diff
(94.1 %id)
BF753364 colon .d 1013 to 1484 499 to 28     Submitted on the opposite strand 472/499
(94 %)
0 diff
(100 %id)
BE835902 prostate_normal .d 1019 to 1310 296 to 5       292/296
(98 %)
1 diff
(99.7 %id)
BI027835 marrow .d 1022 to 1401 419 to 39       381/419
(90 %)
1 diff
(99.8 %id)
AW384438 head_neck .d 1037 to 1521 502 to 17       486/515
(94 %)
7 diff
(98.7 %id)
CU443543 epidermis .d 1038 to 1519 1 to 482       482/489
(98 %)
12 diff
(97.6 %id)
AW384435 head_neck .d 1040 to 1521 489 to 6       484/490
(98 %)
3 diff
(99.4 %id)
AW384440 head_neck .d 1040 to 1521 503 to 21       483/504
(95 %)
3 diff
(99.5 %id)
AW384441 head_neck .d 1040 to 1521 504 to 22       483/505
(95 %)
4 diff
(99.3 %id)
AW384443 head_neck .d 1040 to 1521 487 to 5       483/488
(98 %)
5 diff
(99.0 %id)
AW384444 head_neck .d 1040 to 1521 504 to 22       483/505
(95 %)
3 diff
(99.5 %id)
AW384445 head_neck .d 1040 to 1521 502 to 20       483/503
(96 %)
4 diff
(99.3 %id)
AW384447 head_neck .d 1040 to 1521 507 to 25       483/508
(95 %)
3 diff
(99.5 %id)
BE185559 head_neck .d 1041 to 1371 341 to 11     Submitted on the opposite strand 331/341
(97 %)
0 diff
(100 %id)
ES315627 occipital scalp hair, skin .d 1044 to 1219 1 to 175       175/186
(94 %)
1 diff
(99.5 %id)
AA486518   .d 1045 to 1544 1 to 500   fully sequenced,   500/500
(100 %)
1 diff
(99.8 %id)
BF811349 colon_ins .d 1046 to 1468 444 to 22     Submitted on the opposite strand 423/444
(95 %)
0 diff
(100 %id)
TI_1948214931   .d 1046 to 1305 377 to 118       260/280
(92 %)
0 diff
(100 %id)
TI_154091952   .d 1046 to 1537 616 to 124   AAA   493/494
(99 %)
5 diff
(99.0 %id)
BF819178 colon_ins .d 1050 to 1510 473 to 12     Submitted on the opposite strand 462/473
(97 %)
0 diff
(100 %id)
TI_59383866   .d 1050 to 1544 108 to 602   AAA   495/495
(100 %)
8 diff
(98.4 %id)
AV744223 cord Blood .d 1052 to 1535 492 to 20     Submitted on the opposite strand 473/492
(96 %)
5 diff
(99.0 %id)
AI123109 heart .d 1054 to 1153 100 to 1       100/100
(100 %)
0 diff
(100 %id)
CA848160 Pancreas, Purified pancreatic islet .d 1055 to 1540 486 to 1   fully sequenced,   486/486
(100 %)
0 diff
(100 %id)
AA744080 Prostate, stroma .d 1068 to 1325 303 to 47       257/303
(84 %)
0 diff
(100 %id)
AI146952 senescent fibroblast .d 1072 to 1294 223 to 1       223/223
(100 %)
17 diff
(92.4 %id)
TI_154089441   .d 1072 to 1546 665 to 185   AAA   481/1452
(33 %)
9 diff
(99.4 %id)
CA770983 Pancreas, Purified pancreatic islet .d 1077 to 1538 462 to 1   fully sequenced,   462/462
(100 %)
0 diff
(100 %id)
BF901991 marrow .d 1079 to 1469 391 to 1     Submitted on the opposite strand 391/392
(99 %)
0 diff
(100 %id)
AV735841 cord Blood .d 1081 to 1535 468 to 20     Submitted on the opposite strand 449/471
(95 %)
1 diff
(99.8 %id)
CA776817 Pancreas, Purified pancreatic islet .d 1086 to 1536 451 to 1       451/451
(100 %)
0 diff
(100 %id)
AA534292 colon .d 1087 to 1156 70 to 1       70/70
(100 %)
0 diff
(100 %id)
BE164720 head_neck .d 1088 to 1491 418 to 16     Submitted on the opposite strand 403/418
(96 %)
1 diff
(99.8 %id)
DB552921 hippocampus .d 1092 to 1544 1 to 453     Submitted on the opposite strand 453/453
(100 %)
0 diff
(100 %id)
BQ368090 placenta_normal .d 1102 to 1302 216 to 18       199/216
(92 %)
0 diff
(100 %id)
BE207535 melanotic melanoma, skin .d 1107 to 1541 435 to 1   fully sequenced,   435/435
(100 %)
0 diff
(100 %id)
CA941468 Pancreas, Purified pancreatic islet .d 1107 to 1544 438 to 1   fully sequenced,   438/438
(100 %)
1 diff
(99.8 %id)
AA837979 colon, colon tumor .d 1117 to 1537 419 to 1       419/419
(100 %)
4 diff
(99.1 %id)
TI_1948215110   .d 1118 to 1305 304 to 117       188/208
(90 %)
0 diff
(100 %id)
TI_1948214763   .d 1187 to 1305 238 to 120       119/139
(85 %)
0 diff
(100 %id)
AA412073   .d 1236 to 1544 310 to 1   fully sequenced,   310/310
(100 %)
0 diff
(100 %id)
AA485913   .d 1326 to 1544 218 to 1   fully sequenced,   218/218
(100 %)
0 diff
(100 %id)
BI828473 brain, medulla .e 1 to 811 1 to 810 L168W D169M G170A N171T E172S ... tiling clone,   810/810
(100 %)
1 diff
(99.9 %id)
TI_57175078   .e 1 to 811 68 to 877 L168W D169M G170A N171T E172S ...     810/877
(92 %)
7 diff
(99.3 %id)
BE878458 large cell carcinoma, undifferentiated, lung .e 159 to 768 1 to 626       626/874
(71 %)
45 diff
(94.9 %id)
AV742994 cord Blood .e 178 to 720 68 to 591       528/591
(89 %)
30 diff
(95.0 %id)
AV736899 cord Blood .e 178 to 702 67 to 583       522/592
(88 %)
19 diff
(96.8 %id)
AV743409 cord Blood .e 178 to 713 67 to 585       524/592
(88 %)
21 diff
(96.5 %id)
AV737319 cord Blood .e 178 to 647 67 to 525       464/528
(87 %)
22 diff
(95.9 %id)
AV736340 cord Blood .e 178 to 712 67 to 580       519/586
(88 %)
30 diff
(94.9 %id)
AV738805 cord Blood .e 178 to 546 67 to 431       369/440
(83 %)
24 diff
(94.6 %id)
AV735771 cord Blood .e 178 to 572 67 to 449       388/461
(84 %)
21 diff
(95.5 %id)
AV742557 cord Blood .e 178 to 564 67 to 444       383/455
(84 %)
17 diff
(96.3 %id)
CB854291 lung, Primary Lung Epithelial Cells .e 183 to 763 1 to 581     Submitted on the opposite strand 581/581
(100 %)
0 diff
(100 %id)
BM785317 stomach .e 187 to 772 1 to 586   tiling clone,   586/586
(100 %)
0 diff
(100 %id)
TI_151798132   .e 189 to 780 80 to 670       591/657
(89 %)
15 diff
(97.8 %id)
BF993445 placenta_normal .e 197 to 298 19 to 121       103/121
(85 %)
7 diff
(94.3 %id)
AV740405 cord Blood .e 202 to 592 101 to 482       387/496
(78 %)
15 diff
(97.0 %id)
TI_154143649   .e 204 to 750 85 to 631       547/547
(100 %)
4 diff
(99.3 %id)
EC552059 Prostate .e 206 to 304 1 to 99       99/99
(100 %)
3 diff
(97.0 %id)
AA089503   .e 209 to 428 1 to 219       219/222
(98 %)
15 diff
(93.3 %id)
BF769442 epid_tumor .e 210 to 298 23 to 111       89/111
(80 %)
6 diff
(94.6 %id)
BF769450 epid_tumor .e 210 to 298 22 to 109       88/109
(80 %)
6 diff
(94.5 %id)
W32460 heart .e 224 to 673 1 to 455       455/455
(100 %)
13 diff
(97.2 %id)
TI_154143647   .e 226 to 773 86 to 633       548/548
(100 %)
4 diff
(99.3 %id)
AA092960   .e 228 to 574 1 to 338       338/340
(99 %)
19 diff
(94.5 %id)
TI_151766790   .e 230 to 784 96 to 656       561/1364
(41 %)
32 diff
(97.7 %id)
TI_154141213   .e 238 to 592 81 to 439   AAA   359/742
(48 %)
7 diff
(99.1 %id)
TI_154144353   .e 238 to 780 80 to 623       544/731
(74 %)
9 diff
(98.8 %id)
TI_59383508   .e 248 to 707 138 to 591       456/482
(94 %)
9 diff
(98.2 %id)
TI_154144791   .e 253 to 783 84 to 615       532/540
(98 %)
19 diff
(96.5 %id)
CU450123 epidermis .e 262 to 688 437 to 11     Submitted on the opposite strand 427/457
(93 %)
1 diff
(99.8 %id)
CU452990 epidermis .e 262 to 688 437 to 11     Submitted on the opposite strand 427/457
(93 %)
1 diff
(99.8 %id)
BF329675 breast_normal .e 286 to 628 345 to 2       344/420
(81 %)
6 diff
(98.6 %id)
AA135053 colon, tumor .e 288 to 638 1 to 350       350/350
(100 %)
6 diff
(98.3 %id)
EC459154 Prostate .e 300 to 397 103 to 6       98/103
(95 %)
0 diff
(100 %id)
AW801872 uterus .e 305 to 698 395 to 2       394/404
(97 %)
1 diff
(99.8 %id)
AA132629 colon, tumor .e 306 to 393 1 to 88       88/88
(100 %)
0 diff
(100 %id)
BE933108 head_neck .e 311 to 488 207 to 28       180/215
(83 %)
5 diff
(97.7 %id)
BE697598 colon .e 315 to 565 249 to 2       248/249
(99 %)
1 diff
(99.6 %id)
BE697599 colon .e 315 to 568 264 to 16       249/264
(94 %)
1 diff
(99.7 %id)
BE697600 colon .e 315 to 554 259 to 26       234/259
(90 %)
2 diff
(99.3 %id)
BE697603 colon .e 315 to 520 208 to 5       204/208
(98 %)
3 diff
(98.6 %id)
BE933947 head_neck .e 315 to 572 267 to 10       258/267
(96 %)
0 diff
(100 %id)
BF377805 testis_normal .e 315 to 585 278 to 8       271/278
(97 %)
1 diff
(99.7 %id)
BF993442 placenta_normal .e 315 to 754 458 to 20       439/458
(95 %)
4 diff
(99.2 %id)
BF993446 placenta_normal .e 315 to 754 477 to 39       439/477
(92 %)
0 diff
(100 %id)
BF996788 placenta_normal .e 315 to 777 483 to 24       460/483
(95 %)
3 diff
(99.4 %id)
BQ366574 placenta_normal .e 315 to 763 456 to 3       454/456
(99 %)
17 diff
(96.3 %id)
BQ379495 uterus_tumor .e 315 to 585 278 to 8       271/278
(97 %)
1 diff
(99.7 %id)
BM791660 stomach .e 318 to 564 247 to 1     Submitted on the opposite strand 247/247
(100 %)
2 diff
(99.2 %id)
BF914882 uterus_tumor .e 322 to 659 341 to 4     Submitted on the opposite strand 338/341
(99 %)
0 diff
(100 %id)
BQ292061 amnion_normal .e 322 to 429 1 to 109       109/111
(98 %)
12 diff
(89.2 %id)
AA096479   .e 325 to 541 1 to 211       211/212
(99 %)
18 diff
(91.6 %id)
AA852269 Bone, Hip .e 373 to 666 8 to 300       293/300
(97 %)
6 diff
(98.0 %id)
ES312980 beard hair, skin .e 402 to 588 1 to 187       187/187
(100 %)
2 diff
(99.0 %id)
BQ308596 breast .e 406 to 579 203 to 27       177/203
(87 %)
3 diff
(98.6 %id)
BQ377729 uterus .e 406 to 777 1 to 376       376/387
(97 %)
25 diff
(93.6 %id)
BE835955 prostate_normal .e 440 to 728 290 to 3       288/298
(96 %)
1 diff
(99.7 %id)
AW361059 colon .e 453 to 654 5 to 204       200/204
(98 %)
8 diff
(96.1 %id)
BG994560 head_neck .e 486 to 693 211 to 5       207/211
(98 %)
3 diff
(98.6 %id)
BF154438 breast_normal .e 491 to 735 248 to 6       243/248
(97 %)
1 diff
(99.6 %id)
BE170973 head_neck .e 532 to 658 132 to 6     Submitted on the opposite strand 127/132
(96 %)
1 diff
(99.3 %id)
CU448063 epidermis .e 532 to 688 167 to 11     Submitted on the opposite strand 157/181
(86 %)
4 diff
(97.8 %id)
CA309759 Alveolar Macrophage, lung .e 551 to 760 416 to 207   AAA   210/400
(52 %)
0 diff
(100 %id)
AI831804 B-cell, chronic lymphotic leukemia .e 618 to 781 170 to 6       165/172
(95 %)
0 diff
(100 %id)
AI673772 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .e 673 to 731 61 to 3       59/61
(96 %)
0 diff
(100 %id)
BI761929 pooled colon, kidney, stomach .f 1 to 821 1 to 819 exact tiling clone,   819/971
(84 %)
5 diff
(99.5 %id)
TI_57150986   .f 1 to 821 30 to 848 exact     819/1000
(81 %)
11 diff
(98.9 %id)
BE275455 melanotic melanoma, skin .g 1 to 819 1 to 658 K3N L4A C5V G7E Q9G ... tiling clone,   542/719
(75 %)
50 diff
(93.1 %id)
DB149792 thymus .h-u 1 to 513 2 to 514 exact tiling clone, capped   513/513
(100 %)
2 diff
(99.7 %id)
BG398704 Kidney .i-u 1 to 395 77 to 472 F26L A27P L28S L30W E31S ... tiling clone,   396/818
(48 %)
6 diff
(99.3 %id)
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h-u, .i-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI